Home
Avidity Biosciences

Avidity Biosciences Market Share Analysis for August 2026

Health > Biotechnology and Pharmaceuticals

Domainaviditybiosciences.com

Year Founded2012

Employees201 - 500

Annual Revenue$15M - $25M

Avidity Biosciences

Avidity Biosciences (including company regionals)

aviditybiosciences.com

See more website traffic and engagement information

Avidity Biosciences Revenue up to August 2026 is 15M - 25M

revenue generated by Avidity Biosciences top domains

Avidity Biosciences top domains revenue over 3 years

Revenue for Avidity Biosciences top domains

aviditybiosciences.com15M - 25M

See more with Sales Intelligence

Total visits to Avidity Biosciences's top domains

Understand Avidity Biosciences market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

aviditybiosciences.com7.1K

See more with Sales Intelligence

Avg. visit duration in Avidity Biosciences's top domains

Analyze Avidity Biosciences engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

aviditybiosciences.com00:00:10

See more with Sales Intelligence

Avg. pageviews on Avidity Biosciences's top domains

See how Avidity Biosciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

aviditybiosciences.com1.70

See more with Sales Intelligence

Avidity Biosciences top competitors by domain

Top similar sites in August 2026, ranked by their affinity

arcturusrx.comCompany NameArcturus TherapeuticsEmployees51 - 200HQUnited States, California, San DiegoAnnual revenue$50M - $75MTotal visits23.6KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Avidity Biosciences

These are the website technologies, by industry, used by Avidity Biosciences top domains

Widget (8)

Twemoji

Conversion & Analytics (3)

Google Analytics

Audio Video Media (2)

YouTube

Content Management System (2)

WordPress

More Technologies

6

See all

News & Signals from Avidity Biosciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAvidity Biosciences had revenue of $3M on Aug 13th '26.* Avidity Biosciences beat quarterly expectations: The clinical-stage biotech reported an adjusted loss of $1.18 per share, better than the consensus loss estimate of $1.42, while revenue of $3.0 million exceeded estimates of $0.67 million.

NewsAvidity Biosciences had revenue of $19.6M on May 14th '26.* Avidity's latest quarterly results beat expectations, with an adjusted loss of $0.97 per share versus the $1.05 consensus estimate and revenue of $19.64 million, well above the $2 million forecast.

NewsMike MacLean is planning to leave Avidity Biosciences, Inc. as CFO.Mike MacLean, a current RACC director and former CFO of Avidity Biosciences, will remain on the board post-closing.